MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER VENA VENOUS SELF-EXPANDING STENT; STENT, ILIAC VEIN

Model Number	G57448
Medical Device Problem Codes	No Apparent Adverse Event (3189); Migration (4003)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	06/02/2022
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Qan - common name.P200023 - pma #.Investigation is still pending.A follow up mdr will be submitted to include the investigation conclusions.
Event or Problem Description
As initially reported to customer relations: a female patient in her 60s with compression of the common iliac and external iliac veins on right side underwent an ivus and venography procedure in which the zilver vena venous self-expanding stent, g57449 and g57448, were used.Access site was right groin ivus and venography was performed physician selected 16x140 vena to stent from the confluence into the external iliac vein on right side.No predilation was done.After deploying stent optimally, physician advanced a bard atlas 16x60 balloon into the stent.The tech who was scrubbed in states the physician was not stepping on fluoro while advancing balloon, and once he did step on fluoro both the physician and tech saw that the stent had almost completely, about 95%, migrated into the patient¿s ivc (pr365969).They both agreed that the balloon catheter bumped the caudal edge of the stent and caused it to migrate significantly.Physician attempted to use the bard atlas balloon to pull the stent back down into the common iliac, but was unsuccessful.Then, physician deployed another 16x140 vena into common iliac, overlapping the 2 stents a few centimeters.Due to stent migration, a third stent, the 16x100, was needed to extend into the external iliac.Physician used same 16x60 atlas balloon to post dilate the stents, and as he was advancing the balloon into the 16x100 stent, the balloon bumped into this stent also and caused it to jump about 2 cm but was able to use the balloon to pull the stent back down to original landing zone (pr366108).Did any unintended section of the device remain inside the patient¿s body? if yes, please describe.Was the patient hospitalized or was there prolonged hospitalization? did the patient require any additional procedures due to this occurrence? if yes, please describe.Did the product cause or contribute to the need for additional procedures? if yes, please specify additional procedures and provide details.Has the complainant reported any adverse effects on the patient due to this occurrence? has the complainant reported that the product caused or contributed to the adverse effects? please specify adverse effects and provide details.District managers reply on 16june2022: th 17june2022.Did any unintended section of the device remain inside the patient¿s body? if yes, please describe.No.Was the patient hospitalized or was there prolonged hospitalization? no.Did the patient require any additional procedures due to this occurrence? if yes, please describe.No.Did the product cause or contribute to the need for additional procedures? no.If yes, please specify additional procedures and provide details.Has the complainant reported any adverse effects on the patient due to this occurrence? no.Has the complainant reported that the product caused or contributed to the adverse effects? please specify adverse effects and provide details.No.Prefix zvt7.Are images of the device or procedure available? n/a, yes, no yes will send --- see attached.Did the patient have pre-existing conditions? n/a, yes, no.If yes, please specify: yes history of multiple dvts.Please describe the native state of the vessel (i.E.Was the anatomy tortuous? straight vessel.Was the vessel fibrotic?) n/a, tortuous, calcified, fibrotic, other if other, please specify: somewhat fibrotic.Was a stent previously placed during previous procedures? n/a, yes, no no, just 3 in this procedure.Was the device used percutaneously? n/a, yes, no yes.Where on the patient was the percutaneous access site? right groin.Was the access site jugular or femoral? n/a, jugular, femoral other.If other, please specify: fem.What disease pathology was being treated? may thurner, acute or chronic obstruction, restenosis, other? compression./may thurner.If other, please specify.Was the lesion approached via contralateral or ipsilateral? n/a, contralateral, ipsilateral ipsilateral.Was pre-dilation performed ahead of placement of the stent? n/a, yes, no no.What was the target location for the stent? right external iliac into common fem.Details of access sheath used (name, fr size, length)? terumo, unsure of size was the device flushed through both flushing ports before the procedure, as per ifu? n/a, yes, no yes.Details of the wire guide used (name, diameter, hyrdophyllic)? standard 035 wire, unsure of kind.Was resistance encountered when advancing the wire guide to the target location? n/a, yes, no no.Was resistance encountered when advancing the delivery system to the target location? n/a, yes, no no.If resistance was met, how did the physician address this? did the tip of the delivery system cross the target location? n/a, yes, no yes.Did the user pull the handle towards the hub during deployment, per ifu? n/a, yes, no yes.Did the user push the hub during deployment? n/a, yes, no.Did the user remove slack in the delivery system before deployment, per ifu? n/a, yes, no yes was the stent deployed smoothly / without resistance? n/a, yes, no yes.Was the stent fully deployed in the patient? n/a, yes, no yes.Was the stent fully deployed before removing the delivery system from the patient? n/a, yes, no yes.Was post dilation performed after the placement of the stent? n/a, yes, no yes.Was the delivery system damaged/kinked/twisted during deployment? n/a, yes, no no.What intervention (if any) was required? upon advancing the bard atlas balloon into this stent, the actual balloon caused this stent to move up a couple centimeters up.Balloon was then inflated and used to bring stent back down.Was the secondary intervention performed during the same procedure as the device failure or was it scheduled for another day? n/a, same procedure, another day same.Were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? n/a, yes, no.Please specify if yes.No.
Additional Manufacturer Narrative
Product code - qan, pma # - p200023.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
Event or Problem Description
Supplemental report is being submitted due to medical affairs input received 13-oct-2022: user error 'the stent movement was due to failure to use fluoroscopic imaging during advancement of the balloon.'.
Event or Problem Description
A supplemental report is being submitted due to completion of the investigation on the 09-feb-2023.
Additional Manufacturer Narrative
Product code - qan.Pma # - p200023.Device evaluation: the zvt7-35-80-16-100 device of lot number c1906325 involved in this complaint was implanted in the patient and was not available for evaluation.With the information provided, a document-based investigation was conducted.Lab evaluation: the device evaluation could not be completed as the device was not returned for evaluation.Document review: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity a review of the manufacturing records did not reveal any discrepancies that could have contributed to this complaint issue.There is no evidence to suggest that the customer did not follow the instructions for use it should be noted that the instructions for use (ifu0091) states the following: ¿use caution when re-crossing a stent to avoid stent damage or migration¿.Image review: images were provided to support the complaint investigation.They were reviewed through cook research inc.(cri) and the following comments were provided by the independent reviewer.Impression: 1.The complaint of (b)(4) displacement from the right iliac veins into the ivc is confirmed.Implantation of an additional zvt7 stent to anchor the ivc zvt7 is confirmed.2.Displacement of the anchoring stent from the eiv intended landing zone is confirmed.The third stent extended inferiorly through the original location of the second.3.The post-stent angioplasty balloon was advanced through the complaint stent without fluoroscopic observation.Fluoroscopic observation of device manipulation is standard during interventional vascular procedures.4.The 16mm diameter post stent angioplasty of a 16mm diameter stent did not adhere to ifu recommendations.Either the 16mm balloon was too large or the stent was not appropriately oversized to the iliac veins.5.Normal iliac vein curvature into the out of the pelvis moving superior to inferior and the relatively square shoulders of the atlas gold balloon increased the balloon¿s potential to catch and push the complaint zvt7-35-80-16-140.6.The lesion was likely a non-thrombotic iliac vein lesion (nivl).Root cause review: no root cause determination is required as the complaint is not confirmed.This issue occurred as the physician did not step on the fluoro while advancing the balloon.Once the migrated stent was noticed, the rep and physician agreed that the balloon catheter bumped the edge of the stent and caused it to migrate (captured in (b)(4)).Due to stent migration, another stent was needed to extend into the external iliac.The physician used same balloon to post dilate the stents, and as he was advancing the balloon into the stent, the balloon bumped into this stent also and caused it to jump about 2 cm but was able to use the balloon to pull the stent back down to original landing zone (b)(4).As per clinical input the stent movement was due to the failure to use fluoroscopic imaging during advancement of the balloon.As per engineering input, the issue with these prs of the failure to use fluoroscopic imaging during advancement of the balloon, does not lie with a cook device.The stents migrated as a result of the user advancing the balloon without fluoro and the stents subsequently migrated when the balloon bumped the edge of it.Summary: this complaint (b)(4) is not confirmed.As per engineering input, the issue with this pr of the failure to use fluoroscopic imaging during advancement of the balloon, does not lie with a cook device.The stents migrated as a result of the user advancing the balloon without fluoro and the stents subsequently migrated when the balloon bumped the edge of it.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.They used another vena stent to anchor the migrated stents during the same procedure.Complaints of this nature will continue to be monitored for potential emerging trends.

• Brand Name: ZILVER VENA VENOUS SELF-EXPANDING STENT
• Common Device Name: STENT, ILIAC VEIN
• Manufacturer (Section D): COOK IRELAND LTD; o halloran road; limerick
• Manufacturer (Section G): COOK IRELAND; holstein campus kiel; arnold- keller str- 3; limerick
• Manufacturer Contact: sinead o'leary ; holstein campus kiel; arnold- keller str- 3; limerick
• MDR Report Key: 14883536
• Report Number: 3001845648-2022-00390
• Device Sequence Number: 12034397
• Product Code: QAN
• UDI-Device Identifier: 10827002574486
• UDI-Public: (01)10827002574486(17)250121(10)C1906325
• Combination Product (Y/N): N
• Initial Reporter State: FL
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2022
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Health Professional,User Facility,Company Representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 02/09/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 02/02/2025
• Device Model Number: G57448
• Device Catalogue Number: ZVT7-35-80-16-100
• Device Lot Number: C1906325
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Distributor Facility Aware Date: 06/02/2022
• Event Location: Hospital
• Type of Report(Section G): Initial
• Initial Date Received by Manufacturer: 06/09/2022
• Supplement Date Received by Manufacturer: 06/09/2022; 06/09/2022
• Initial Report FDA Received Date: 07/01/2022
• Supplement Report FDA Received Date: 11/11/2022; 03/07/2023
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 02/02/2022
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Female